dc.date.accessioned2022-10-10T00:48:55Z
dc.date.available2022-10-10T00:48:55Z
dc.date.created2022-10-10T00:48:55Z
dc.date.issued1995
dc.identifierhttps://hdl.handle.net/20.500.12866/12328
dc.identifierhttps://doi.org/10.1093/clinids/20.6.1480
dc.description.abstractWe conducted a randomized double-blinded study in Lima, Peru, to assess the tolerability and efficacy of a single 250-mg dose of ciprofloxacin in preventing diarrhea and Vibrio cholerae O1 infection among household contacts of bacteriologically confirmed index cases. Adult household contacts with negative baseline stool cultures were included. A total of 213 household contacts were evaluable. The study drugs were well tolerated in both groups. Ciprofloxacin did not prevent the acquisition of V. cholerae O1 infection nor the development of diarrhea. However, in a subgroup of 30 household contacts with positive baseline stool cultures a reduction in the bacterial load and a trend toward prevention of diarrhea were observed among ciprofloxacin recipients. When all household contacts were evaluated, a trend toward prevention of diarrhea was observed with the prophylactic regimen. Ciprofloxacin failed to prevent V. cholerae O1 infections during a period of low transmissibility.
dc.languageeng
dc.publisherOxford University Press
dc.relationClinical Infectious Diseases
dc.relation1537-6591
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectcholera
dc.subjectciprofloxacin
dc.subjectdiarrhea
dc.subjectadult
dc.subjectperu
dc.subjectinfections
dc.subjectstool culture
dc.subjectprevention
dc.subjectvibrio cholerae
dc.titleEfficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with cholera
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución